T. Rowe Price Associates’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $15.2M | Sell |
|
|||||
|
2024
Q4 | $49.3M | Sell |
|
|||||
|
2024
Q3 | $76.3M | Sell |
|
|||||
|
2024
Q2 | $97.8M | Buy |
|
|||||
|
2024
Q1 | $83.3M | Sell |
|
|||||
|
2023
Q4 | $90.3M | Buy |
|
|||||
|
2023
Q3 | $34.2M | Buy |
|
|||||
|
2023
Q2 | $41.6M | Buy |
|
|||||
|
2023
Q1 | $29.5M | Buy |
|
|||||
|
2022
Q4 | $28.2M | Buy |
|
|||||
|
2022
Q3 | $16.3M | Buy |
|
|||||
|
2022
Q2 | $2.33M | Buy |
|
|||||
|
2022
Q1 | $2.43M | Buy |
|
|||||
|
2021
Q4 | $1.89M | Sell |
|
|||||
|
2021
Q3 | $1.51M | Buy |
|
|||||
|
2021
Q2 | $1.48M | Sell |
|
|||||
|
2021
Q1 | $1.37M | Buy |
|
|||||
|
2020
Q4 | $1M | Sell |
|
|||||
|
2020
Q3 | $8.04M | Sell |
|
|||||
|
2020
Q2 | $24.7M | Sell |
|
|||||
|
2020
Q1 | $23M | Buy |
|
|||||
|
2019
Q4 | $44.4M | Buy |
|
|||||
|
2019
Q3 | $542K | Sell |
|
|||||
|
2019
Q2 | $4.61M | Sell |
|
|||||
|
2019
Q1 | $4.34M | Buy |
|
|||||
|
2018
Q4 | $4M | Sell |
|
|||||
|
2018
Q3 | $9.57M | Sell |
|
|||||
|
2018
Q2 | $14.9M | Sell |
|
|||||
|
2018
Q1 | $24.1M | Buy |
|
|||||
|
2017
Q4 | $354K | Buy |
|
|||||
|
2017
Q3 | $261K | Buy |
|
|||||
|
2017
Q2 | $176K | Sell |
|
|||||
|
2017
Q1 | $7.85M | Sell |
|
|||||
|
2016
Q4 | $7.8M | Sell |
|
|||||
|
2016
Q3 | $8.59M | Buy |
|
|||||
|
2016
Q2 | $373K | Buy |
|
|||||
|
2016
Q1 | $266K | Buy |
|